Screener
Collegium Pharmaceutical, Inc. COLL Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $4.97M.
The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053851
FAQ
- What is Collegium Pharmaceutical, Inc.'s total debt?
- Collegium Pharmaceutical, Inc. (COLL) reported total debt of $4.97M in Q2 2026.
- How has Collegium Pharmaceutical, Inc.'s total debt changed year-over-year?
- Collegium Pharmaceutical, Inc.'s total debt decreased by 19.8% year-over-year, from $6.19M to $4.97M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s total debt?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s total debt has grown at a -10.2% compound annual growth rate (CAGR), from $9.5M to $5.54M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Collegium Pharmaceutical, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude